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Abstract
Background: Hereditary spastic paraplegias are a group of neurological disorders characterized by progressive
distal degeneration of the longest ascending and descending axons in the spinal cord, leading to lower limb
spasticity and weakness. One of the dominantly inherited forms of this disease (spastic gait type 10, or SPG10) is
caused by point mutations in kinesin-1A (also known as KIF5A), which is thought to be an anterograde motor for
neurofilaments.
Results: We investigated the effect of an SPG10 mutation in kinesin-1A (N256S-kinesin-1A) on neurofilament
transport in cultured mouse cortical neurons using live-cell fluorescent imaging. N256S-kinesin-1A decreased both
anterograde and retrograde neurofilament transport flux by decreasing the frequency of anterograde and
retrograde movements. Anterograde velocity was not affected, whereas retrograde velocity actually increased.
Conclusions: These data reveal subtle complexities to the functional interdependence of the anterograde and
retrograde neurofilament motors and they also raise the possibility that anterograde and retrograde neurofilament
transport may be disrupted in patients with SPG10.
Background
Hereditary spastic paraplegias are a group of neurologi-
cal disorders characterized by progressively increasing
lower-extremity weakness and spasticity [1]. The pri-
mary cause appears to be distal degeneration of the
longest ascending and descending axons in the spinal
cord, though the explanation for this selective vulner-
ability is not known. To date, at least 41 spastic paraple-
gia gene loci have been mapped (termed SPG1 through
SPG 41) and 17 genes have been identified [2]. The
inheritance can be autosomal dominant, autosomal
recessive, or X-linked. One of the autosomal dominant
forms, SPG10, is caused by mutations in kinesin-1A,
also known as KIF5A, which is a member of the kine-
sin-1 family of motor proteins.
Kinesin-1 motor proteins are heterotetramers com-
posed of two heavy chains and two light chains [3].
There are three kinesin-1 heavy chain genes in mam-
mals: kinesin-1A, B and C (also known as KIF5A, B and
C) [4]. Kinesin-1A and kinesin-1C are neuron specific,
whereas kinesin-1B ("conventional kinesin”) is expressed
ubiquitously [5-7]. Little is known about the cargoes of
kinesin-1A, though potential cargoes and interactors
include HAP-1 (huntingtin associated protein-1) [8],
DISC-1 (disrupted in schizophrenia protein-1) and the
NUDEL/LIS1/14-3-3ε complex [9], Grb2 (growth factor
receptor bound protein-2) [10], and b-dystrobrevin
[11,12].
Neurofilaments are the intermediate filaments of neu-
rons. They are heteropolymers of variable composition
and subunit stoichiometry, typically composed of the
low, medium and high molecular weight neurofilament
triplet proteins (NFL, M and H), as well as peripherin
and/or alpha-internexin [13]. Live-cell imaging of neuro-
filament transport in cultured neurons and computa-
tional modeling studies of neurofilament transport in
vivo have demonstrated that neurofilaments move along
axons in a rapid, intermittent and bidirectional manner
[14-17].
Studies on kinesin-1A knockout mice have suggested
that kinesin-1A may be an anterograde motor for neu-
rofilaments in axons [18]. In support of this proposal,
we observed a 75% reduction in the frequency of neuro-
filament movement in cultured neurons from kinesin-
1A knockout mice [19]. Interestingly, both anterograde
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in both directions could be rescued by kinesin-1A. Par-
tial rescue was also observed with kinesin-1B and kine-
sin-1C, though with successively decreasing efficacy. In
addition, headless kinesin-1A and kinesin-1C each
inhibited both anterograde and retrograde neurofilament
transport in a dominant-negative manner in wild type
neurons. Because dynein is thought to be the retrograde
motor for axonal neurofilaments, we investigated the
effect of dynein inhibition on neurofilament transport.
Disruption of dynein function by using RNA interfer-
ence, dominant- negative approaches, or a function-
blocking antibody also inhibited both anterograde and
retrograde neurofilament movement. These data suggest
that kinesin-1A is the principal but not exclusive antero-
grade motor for neurofilaments, that there may be some
functional redundancy among the kinesin-1 isoforms
with respect to neurofilament transport, and that the
activities of the anterograde and retrograde neurofila-
ment motors are tightly coupled.
Since kinesin-1A appears to be a motor for neurofila-
ments, we have investigated the effect of an SPG10
mutation in this motor on neurofilament transport in
cultured neurons. Of the 16 different SPG10 mutations
that have been identified to date, 15 reside in the kine-
sin motor domain and 14 of these are missense
mutations [20-26]. A particular hot spot for these muta-
tions is in the vicinity of the microtubule and nucleotide
binding sites. In the present study, we have focused on
the N256S mutation, which results in the substitution of
a highly conserved asparagine residue in the switch II
loop/helix motif of the microtubule binding site [20]
(Figure 1). We show that expression of N256S-kinesin-
1A disrupts both anterograde and retrograde neurofila-
ment neurofilament transport in cultured mouse cortical
neurons, raising the possibility that neurofilament trans-
port may also be disrupted in patients with SPG10.
Results
To study the effect of N256S-kinesin-1A on neurofila-
ment transport, we transfected cultured mouse cortical
neurons with GFP-tagged neurofilament protein M
(GFP-NFM) with or without mutant or wild type mouse
kinesin-1A. The purpose of the wild type kinesin-1A
was to control for possible effects due to overexpression
of the motor. Mouse cortical neurons exhibit gaps in
the axonal neurofilament array similar to those that we
have observed in neurons from superior cervical ganglia
[14-19], but the gaps in the cortical neurons are longer
and more numerous, making these cells particularly sui-
table for studies of neurofilament movement (Figure 2).
The GFP-NFM fusion protein incorporates throughout
Figure 1 Sequence comparison of mouse and human kinesin-1A. Sequence alignment of kinesin-1A in mice (Genbank Accession number
NP_001034089) and humans (Genbank Accession number NP_004975). The motor domain spans residues 1 through 336 and is identical except
for conserved substitutions at residues 41 and 218. The N256S mutation occurs at an invariant asparagine residue (highlighted in inverted
contrast) located in the switch II loop/helix motif of the microtubule binding site.
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rofilaments to be detected. Additional files 1 & 2 in the
Supplementary Data are examples of movies showing
the abundant neurofilament movement that can be
observed in these neurons.
To track the movement of the GFP-tagged neurofila-
ments, we observed gaps by epifluorescence microscopy
and acquired time-lapse movies using one second expo-
sures at four second time intervals. Each movie was
exactly 15 minutes in length. Ninety six percent of the
moving structures were filamentous in shape, ranging
from 1.3 μm to 44.5 μm in length and diffraction limited
in width. The average length was 8.6 μm, which is com-
parable to what we observed in previous studies on neu-
rons from mouse superior cervical ganglia [19-27]. We
defined transport frequency as the number of filaments
that moved at least 50 pixels (6.55 μm) per 15-minute
movie. N256S-kinesin-1A reduced the average neurofila-
ment transport frequency significantly, from 4.5 to 1.4
filaments/hour in the anterograde direction (p < 0.001)
and from 3.2 to 2.0 filaments/hour in the retrograde
direction (p = 0.047; Figure 3). Expression of wild type
kinesin-1A reduced the average neurofilament transport
frequency from 4.5 to 3.7 filaments/hour anterogradely
and from 3.2 to 3.1 filaments/hour retrogradely, but
these effects were not statistically significant (p = 0.26
and p = 0.92, respectively). Thus N256S-kinesin-1A
impaired neurofilament transport in both anterograde
and retrograde directions in these axons. Additional files
3, 4 & 5 in the Supplementary Data are examples of the
movies obtained in these experiments.
To analyze the motility defect in more detail, we
tracked the movement of each filament through succes-
sive frames of the time-lapse movies. We defined ante-
rograde and retrograde transport flux as the total
distance moved in the corresponding direction by all the
filaments in each 15-minute movie. Since each movie
contained a single axon, we expressed the fluxes in units
of μm/axon/hour. N256S-kinesin-1A reduced the aver-
age neurofilament transport flux from 149 to 46 μm/
axon/hour in the anterograde direction (p < 0.001) and
from 116 to 90 μm/axon/hour in the retrograde direc-
tion (p = 0.007; Figure 3). Expression of wild type kine-
sin-1A reduced the transport flux from 149 to 109 μm/
axon/hour anterogradely and from 116 to 105 μm/axon/
hour retrogradely, but these reductions were not statisti-
cally significant (p = 0.13 and p = 0.69, respectively).
Thus, in addition to decreasing the frequency of neuro-
filament movement, N256S-kinesin-1A also decreased
the total extent of neurofilament movement.
To determine whether N256S-kinesin-1A also affected
the velocity or persistence of neurofilament movement,
Figure 2 A neurofilament moving through a gap in the axonal
neurofilament array. Axon of a cortical neuron expressing GFP-
NFM, visualized by epifluorescence microscopy. The axons exhibit
discontinuities in the axonal neurofilament array, which we call
gaps. Filaments that move into the gaps can be tracked by time-
lapse imaging to analyze the kinetics of movement. These images
are excerpted from the movie named Additional file 3 in the
Supplementary Data. Proximal is left and distal is right. Scale bar =
10 μm.
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bout of movement for each moving filament. We
defined a bout as a period of uninterrupted movement
between two pauses or between a pause and a reversal.
N256S-kinesin-1A decreased the average bout velocity
from 0.27 μm/s to 0.24 μm/s in the anterograde direc-
tion, but this was not statistically significant (p = 0.053;
Figure 4). In contrast, N256S-kinesin-1A increased the
average retrograde bout velocity from 0.32 to 0.40 μm/s,
and this was statistically significant (p < 0.001). N256S-
kinesin-1A also increased the average retrograde bout
distance from 3.7 μmt o5 . 7μm (p < 0.001) and the
average retrograde bout duration from 11 seconds to 15
seconds (p < 0.001), but without any significant effect
on average anterograde bout distance (3.2 μm, p = 0.36)
or average anterograde bout duration (19 seconds, p =
0.98). Expression of wild type kinesin-1A had no signifi-
cant effect on average retrograde bout velocity (0.30
μm/s, p = 0.76), average retrograde bout distance (3.4
μm, p = 0.57), or average retrograde bout duration (14
seconds, p = 0.32). Expression of wild type kinesin-1A
did decrease the average anterograde bout velocity from
0.27 μm/s to 0.23 μm/s (p = 0.006) and average antero-
g r a d eb o u td i s t a n c ef r o m3 . 4μmt o3 . 0μm (p = 0.043),
but without any significant effect on average anterograde
bout duration (15 seconds, p = 0.31). Thus, N256S-kine-
sin-1A reduced the anterograde flux by decreasing ante-
rograde frequency without affecting anterograde
Figure 3 Effect of N256S-kinesin-1A on the frequency and flux of neurofilament movement. Analysis of neurofilament movement through
gaps in axons of cortical neurons expressing GFP-NFM alone (A & D; 51 movies), GFP-NFM plus N256S-kinesin-1A (B & E; 40 movies), or GFP-NFM
plus exogenous wild type kinesin-1A (C & F; 50 movies). (A-C) Histograms of the frequencies of neurofilament movement, expressed as number
of neurofilaments per hour. The filaments were classified as anterograde or retrograde based on their preferred direction of movement and an
anterograde and retrograde frequency was calculated for each movie. (see Methods). (D-F) Histograms of the neurofilament fluxes, expressed as
total distance moved by all the filaments per axon per hour in either the anterograde or retrograde direction. An anterograde and retrograde
flux was calculated for each movie.
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Page 4 of 13Figure 4 Effect of N256S-kinesin-1A on the velocity, distance and duration of bouts of neurofilament movement. Analysis of the
velocity, distance and duration of bouts of neurofilament movement in axons of cortical neurons expressing GFP-NFM alone (A, D & G; 246
anterograde bouts, 212 retrograde bouts), GFP-NFM plus N256S-kinesin-1A (B, E & H; 84 anterograde bouts, 91 retrograde bouts), or GFP-NFM
plus exogenous wild type kinesin-1A (C, F & I; 254 anterograde bouts, 223 retrograde bouts). The anterograde and retrograde bouts are
represented by the dark grey and light grey bars, respectively. The y-axis represents the percentage of bouts in the corresponding direction.
Note: to avoid compressing the scale on the x-axis, the right-most bin represents an expanded bin size of 30-50 in graphs D-F, and 100-500 in
graphs G-I.
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flux in spite of an increase in retrograde velocity
because the increase in retrograde velocity was not suffi-
cient to compensate for the decrease in retrograde fre-
quency (summarized in Figure 5).
We have shown previously that neurofilaments are
delivered to distal axons by anterograde movement and
retrieved by retrograde movement [27]. Thus it is possi-
ble that the decrease in retrograde flux described above
could be explained by a depletion of neurofilaments
from distal axons as a secondary consequence of the
disruption of anterograde movement. To test this
hypothesis, we transfected cultured cortical neurons
with GFP-NFM, either with or without N256S-kinesin-
1A, and then fixed and processed the cells for immuno-
fluorescence microscopy after 10-11 days in culture
using antibodies specific for GFP and neurofilament
protein M (NFM). Since axonal neurofilament distribu-
tion is discontinuous in these neurons, we also stained
for tubulin and actin, which are present along the entire
length of each axon. Cells expressing N256S-kinesin-1A
were identified by their GFP expression. To quantify
neurofilament content, we measured the fluorescence
intensity of NFM in distal axons, extending 100 μm
proximally from the base of the growth cone. There was
no statistically significant difference in the neurofilament
content of axons expressing N256S-kinesin-1A com-
pared to axons expressing no exogenous kinesin-1A
(Figure 6). Thus, disruption of neurofilament transport
by N256S-kinesin-1A does not appear to deplete distal
axons of neurofilaments, and therefore the reduction in
retrograde neurofilament flux cannot be a secondary
consequence of the disruption of anterograde neurofila-
ment movement. The absence of a reduction in neurofi-
lament content in distal axons expressing N256S-
kinesin-1A is probably due to the impairment of both
anterograde and retrograde neurofilament movement,
which would be expected to impair both delivery and
departure of neurofilaments from these axonal regions.
Microtubules in axons are widely accepted to be
orientated exclusively with their plus-ends distal, and
kinesin-1 motors are known to move cargoes exclusively
toward the plus-ends of these polymers. Thus the dis-
ruption of retrograde neurofilament movement by
N256S-kinesin-1A suggests that this mutant also dis-
rupts minus-end directed neurofilament movement,
which is thought to be mediated by dynein [28-31].
However, another possibility, albeit unlikely, is that
microtubule polarity in cultured mouse cortical axons is
not entirely or predominantly plus-end distal. To test
this hypothesis, we transfected cultured cortical neurons
with the microtubule plus-end tracking protein EB1
tagged with yellow fluorescent protein (YFP-EB1) and
imaged the movement of YFP-EB1 comets. Additional
file 6 in the Supplementary Data is an example of a
movie showing YFP-EB1 comet movement in these
cells. Using kymograph analysis, we tracked 192 comets
in 23 axons. 190 comets moved anterogradely and 2
comets moved retrogradely (Figure 7). The average
comet velocity was 0.13 μm/s, which is consistent with
published estimates of the rate of microtubule growth in
cells [32]. These data confirm that microtubules in these
axons are indeed almost exclusively plus-end distal
Figure 5 Summary of kinetic data. Bar graphs summarizing the
kinetics of neurofilament movement in axons of cortical neurons
expressing GFP-NFM alone, GFP-NFM plus N256S-kinesin-1A, or GFP-
NFM plus exogenous wild type kinesin-1A. Graphs A-D summarize
the data in Figure 3 and graphs E-J summarize the data in Figure 4.
The asterisks denote the p values comparing the GFP-NFM plus
N256S-kinesin-1A and the GFP-NFM plus exogenous wild type
kinesin-1A to GFP-NFM alone (Mann-Whitney test: *** = p < 0.005;
** = p < 0.01; * = p < 0.05).
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microtubules could represent microtubules that looped
back on themselves). Thus the disruption of retrograde
neurofilament transport by N256S-kinesin-1A appears
to be due to disruption of minus-end directed move-
ment by this mutant plus-end directed motor.
Discussion
The SPG10 form of hereditary spastic paraplegia is an
autosomal dominant disease caused by mutations in the
kinesin-1A motor protein. Since there is evidence that
kinesin-1A is a motor for neurofilaments, we investi-
gated the effect of an SPG10 mutant, N256S-kinesin-1A,
on neurofilament transport in cultured neurons. Expres-
sion of N256S-kinesin-1A in cultured mouse cortical
neurons impaired neurofilament transport in both ante-
rograde and retrograde directions, but unexpectedly this
was due primarily to a decrease in the frequency, not
the velocity of movement. A limitation of our experi-
mental approach is that transient transfection of the
mutant motor does not permit quantification or regula-
tion of the expression level relative to the endogenous
wild type motor. Therefore, to control for possible
effects of over-expression, we also characterized neurofi-
lament movement in neurons transfected with wild type
kinesin-1A motor. Simply over-expressing wild type
kinesin-1A had a small effect on anterograde bout velo-
city and anterograde bout distance, but no effect on
average frequency or flux in either the anterograde or
retrograde direction. Thus the effects of the N256S-
kinesin-1A on neurofilament transport were due to the
N256S mutation and were not an artifact of over-
expression.
The impairment of both anterograde and retrograde
neurofilament movement in these experiments is nota-
ble because kinesin-1A is an anterograde motor in
axons, but this result is consistent with recent evidence
from our laboratory showing that the anterograde and
retrograde neurofilament motors are interdependent
[19]. In that study, we found that both anterograde and
retrograde neurofilament movement were impaired in
neurons from kinesin-1A knockout mice, and that
expression of wild type kinesin-1A rescued the move-
ment in both directions. In addition, expression of a
headless dominant negative kinesin-1A construct in wild
type neurons impaired both anterograde and retrograde
neurofilament movement, and disruption of dynein
function by using RNA interference, dominant negative
approaches, or a function-blocking antibody also inhib-
ited both anterograde and retrograde neurofilament
Figure 6 N256S-kinesin-1A does not deplete neurofilaments from distal axons. Comparison of the neurofilament content of distal axons
from cortical neurons expressing GFP-NFM alone (control) or GFP-NFM plus N256S-kinesin-1A. (A) Immunofluorescence microscopy for
neurofilament protein (top panels) and for tubulin and actin (bottom panels; see Methods). Scale bar = 20 μm. (B) Quantification of
neurofilament content in distal axons. There was no significant difference in the neurofilament content of axons expressing GFP-NFM plus
N256S-kinesin-1A (49 axons) compared to control axons expressing GFP-NFM alone (49 axons; p = 0.73, Mann-Whitney test).
Wang and Brown Molecular Neurodegeneration 2010, 5:52
http://www.molecularneurodegeneration.com/content/5/1/52
Page 7 of 13movement. Thus there is functional coupling between
kinesin-1A and dynein motors in the bidirectional trans-
port of neurofilaments along microtubules in axons.
The mechanism by which microtubule motors of
opposing directionality interact to regulate bidirectional
cargo transport is not yet understood. Two favored
models are the tug-of-war model and the coordination
model [33]. In the tug-of-war model, the direction of
movement is the result of a dynamic competition
between opposing motors that are bound and active at
the same time. In the coordination model, the opposing
motors interact so that only motors of one directionality
are bound or active at one time. In their simplest form,
these two models have quite different predictions: in the
tug-of-war model, impairment of motors of one direc-
tionality should increase the velocity and frequency of
movement in the opposite direction, whereas in the
coordination model it should not. In fact, according to
the coordination model, manipulations or mutations
that disrupt the coordination could also cause the
motors to interfere with each other, leading to impair-
ment of movement in both directions [34]. Many labs
have reported reciprocal inhibition of both directions of
movement after disruption of motors of one directional-
ity, which is consistent with the coordination model (see
[19] for citations to these studies).
In the present study, we found that expression of
N256S-kinesin-1A reduced the frequency and flux of
Figure 7 Microtubules in cortical neuron axons are plus-end distal. Cortical neurons were transfected with YFP-EB1, which is a protein that
binds to the growing plus ends of microtubules. Axons were imaged for 2 minutes at 2 second intervals in order to determine the direction of
microtubule growth. (A) A typical kymograph showing a number of YFP-EB1 comets moving anterogradely. The horizontal dimension represents
distance and the vertical dimension represents time. This kymograph was generated from the movie named Additional file 6 in the
Supplementary Data. (B) Histogram of YFP-EB1 comet velocities (192 comets from 23 different neurons). Note that almost all the comets move
anterogradely, confirming the plus-end distal orientation of the microtubules in these axons.
Wang and Brown Molecular Neurodegeneration 2010, 5:52
http://www.molecularneurodegeneration.com/content/5/1/52
Page 8 of 13neurofilament movement in both anterograde and retro-
grade directions and increased bout velocity, distance
and duration in the retrograde direction. It is unclear
how to interpret these data mechanistically. The
decrease in both anterograde and retrograde frequency
and flux suggests a coordination mechanism, but the
increase in retrograde bout velocity, distance and dura-
tion suggests a tug-of-war. Thus it is likely that the
mechanism is more complex, perhaps combining fea-
tures of both models. For example, Lipowsky and collea-
gues have shown that tug-of-war models that account
for the load-dependence of the interaction between
motors and their tracks can generate bouts of persistent
anterograde and retrograde movement, depending on
the relative numbers of bound motors [35,36]. To test
such hypotheses in the case of neurofilaments it will be
necessary to record neurofilament movement with much
higher spatial and temporal resolution than we have
done in the present study, and also to measure the
forces acting on the moving filaments, which is cur-
rently not possible because neurofilaments are too small
to be optically trapped.
Studies in vitro suggest that the N256S-kinesin-1A
mutant is a defective motor and that it may act as a
dominant-negative disruptor of kinesin-1A transport.
Mutation of the homologous amino acid residue to a
lysine in the motor domain of the yeast kinesin-14
motor kar3 (N650K-kar3) or in the motor domain of
the fungal kinesin-14 motor ncd (N600K-ncd), prevents
microtubule-stimulated activation of the motor ATPase
by uncoupling nucleotide and microtubule binding [37].
Both N650K-kar3 and N600K-ncd are capable of bind-
ing and hydrolyzing ATP, but in contrast to wild type
kinesin, they bind tightly to microtubules in both the
ATP-bound and ADP-bound states. In microtubule glid-
ing assays in vitro, N600K-ncd motors bind microtu-
bules but do not translocate them. In yeast cells,
N650K-kar3 exhibits a dominant negative effect over
wild-type kar3 [38]. In vitro, N256S-kinesin-1A is unable
to generate single-motor processive motion in microtu-
bule gliding and bead motility assays, resulting in
decreased gliding and transport velocities [39]. However,
in contrast to the N to K mutations in N650K-kar3 and
N600K-ncd, the N256S mutation in kinesin-1A did not
bind microtubules in rigor. When N256S-kinesin-1A
was mixed with wild type kinesin-1A in microtubule
gliding and particle motility assays in vitro, the mutant
kinesin appeared to exert a dominant inhibitory effect
on the transport velocity. Given these observations,
however, it is surprising that the disruption of neurofila-
ment transport by N256S-kinesin-1A in our study was
due primarily to a decrease in the frequency. There was
a slight decrease in average velocity (from 0.27 to 0.24
μm/s), but this was not statistically significant.
Moreover, this effect was probably an artifact of over-
expression, since we observed a similar decrease in cells
expressing wild type kinesin-1A. Thus the behavior of
the motor in motility assays in vitro cannot necessarily
predict its effect on cargo transport in vivo.
Neurofilaments accumulate abnormally and exces-
sively in many neurodegenerative diseases, including
amyotrophic lateral sclerosis, giant axonal neuropathy,
and Charcot Marie Tooth disease [40,41]. Several stu-
dies have suggested that these accumulations may arise
due to perturbations in axonal transport [42-44]. In sup-
port of this idea, slowing of axonal transport has been
reported in mouse models of SOD-mediated amyo-
trophic lateral sclerosis [45] and is an early event in the
progression of this disease [46]. Disruption of axonal
transport by over-expression of dynamitin in neurons
also results in accumulations of neurofilaments [47], and
mutations in dynein subunits are one cause of motor
neuron disease in humans [48,49]. Defects in axonal
transport have also been reported in mouse models of
spastin-mediated hereditary spastic paraplegia (SPG4)
[50,51], and swellings containing vesicular and cytoske-
letal proteins, including neurofilament proteins, have
been reported in humans with this disease [50,51].
While it is clear that the axonal transport of neurofila-
ments is impaired in many neurodegenerative diseases,
the role of neurofilament accumulations in the disease
progression has been controversial. Over-expression of
the human high molecular weight neurofilament protein
(NFH) in mice causes a slowing of neurofilament trans-
port, accumulations of axonal neurofilaments, and
motor neuron degeneration [42-52]. However, the sig-
nificance of these studies is unclear because over-
expression of mouse NFH has no pathological effects
[53]. One approach to test the role of neurofilaments in
mouse models of neurodegenerative diseases has been
to cross the mice with neurofilament L knockout mice,
which lack neurofilament polymers. Using this approach,
it has been shown that the absence of neurofilaments in
neurons slows the progression of disease dramatically in
mouse models of superoxide dismutase (SOD)-mediated
ALS [54,55]. On the other hand, similar experiments
using a transgenic mouse expressing an NFH b-galacto-
sidase fusion protein, which aggregates and sequesters
neurofilaments in neuronal cell bodies, showed no sig-
nificant alteration of disease pathology in mouse models
of dystonia musculorum and SOD-mediated ALS,
though there was some prolongation of neuronal survi-
val and some delay of axon loss [56].
Apparently contradictory results on the role of neuro-
filaments in disease have also been obtained in experi-
ments on the accumulation of neurofilaments in
response to neurotoxins such as acrylamide and hexane-
dione. These agents impair or accelerate axonal
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to focal accumulations and depletions of axonal neurofi-
laments. Studies with transgenic mice expressing NFH
b-galactosidase fusion protein suggest that neurofila-
ments are not essential for the toxicity associated with
the administration of these substances [57], whereas stu-
dies on the Quiverer (Quv) quail, which lack NFL, sug-
gest that they are [58]. Perhaps the conflicting nature of
these reports may be due to differences between the ani-
mal models used. For example, the NFH b-galactosidase
transgenic mice have perikaryal neurofilament accumu-
lations whereas the NFL knockout mice and the Qui-
verer quail do not. Whatever the explanation, however,
it does seem clear that the accumulation of neurofila-
ments can be an exacerbating factor in at least some
circumstances.
Neurofilaments are unlikely to be the sole cargo for
kinesin-1A in neurons so it is possible that deficiencies
in the movement of other cargoes may contribute to the
disease progression in SPG10. Moreover, while neurofi-
lament accumulations have been described in patients
with SPG4 (see above), there have been no ultrastruc-
tural studies on nerves of patients with SPG10. Thus it
is presently unclear whether neurofilament accumula-
tions are a feature of this disease. In the present study
we did not observe local neurofilament accumulations
in axons of neurons expressing N256S-kinesin-1A. How-
ever, it is unclear to what extent such observations in
short term cultures can predict the long-term effects of
SPG10 mutaions on neurofilament organization in vivo.
For example, it is quite possible that subtle changes in
neurofilament organization or distribution in short-term
cultures of neonatal cultured neurons might be magni-
fied over longer time scales in mature neurons in vivo.
Either way, the fact that kinesin-1A appears to be a neu-
rofilament motor and that N256S-kinesin-1A disrupts
the bidirectional transport of neurofilaments in cultured
neurons suggest that patients with the SPG10 form of
hereditary spastic paraplegia may well have neurofila-
ment transport abnormalities which may contribute to
the disease progression, and this warrants further
investigation.
Conclusions
Mutations in kinesin-1A, which is a putative antero-
grade motor for axonal neurofilaments, cause the SPG10
form of hereditary spastic paraplegia. We investigated
the effect of an SPG10 point mutation in kinesin-1A on
neurofilament transport in cultured mouse cortical neu-
rons. We showed that this mutant disrupts both antero-
grade and retrograde neurofilament transport, raising
the possibility that neurofilament transport may also be
disrupted in patients with SPG10.
Materials and methods
Molecular Cloning
Mouse kinesin-1A cDNA (Genbank accession No.
BC058396, I.M.A.G.E. clone 6824963) was obtained
from American Type Culture Collection (Manassas, VA)
and then subcloned into pEGFP-C1 (Clontech, Moun-
tain View, CA) lacking the EGFP sequence, as previously
described [19]. The N256S-kinesin-1A plasmid construct
was generated using a QuikChange Site-Directed Muta-
genesis Kit (Stratagene, La Jolla, CA) with forward pri-
mer 5’-GGC AAA GAA TAT CAG CAA GTC GCT
GTC GGC CC and reverse primer 5’-GGG CCG ACA
GCG ACT TGC TGA TAT TCT TTG CC. The wild
type and mutant kinesin-1A constructs were tagged
with cMyc at their N-terminus with forward primer 5’-
CTA GCT CCG GAA TGG AGC AGA AGC TGA
TCA GCG AGG AGG ACC TGG AG and reverse pri-
mer 5’-TCG ACT CCA GGT CCT CCT CGC TGA
TCA GCT TCT GCT CCA TTC CGG AG. The result-
ing cMyc-N256S-kinesin-1A and cMyc-kinesin-1A con-
structs were confirmed by DNA sequencing of their
open reading frames. The EGFP-mNFM plasmid con-
struct, which encodes the codon-optimized F64L/S65T
variant of green fluorescent protein attached to the
amino terminus of mouse neurofilament protein M, was
described by Yan et al. [59]. The YFP-EB1 plasmid con-
struct was provided by Chen Gu [60].
Cell culture
Cortical neurons were cultured using the glial sandwich
technique of Banker [61]. To prepare glial cultures, the
cerebral cortices of 3 to 5 P0 mice were dissociated in
phosphate buffered saline (PBS; Invitrogen, Carlsbad,
CA) containing 0.25% [w/v] trypsin (Worthington Bio-
chemical Corp., Lakewood, NJ), 1% [w/v] DNase-I
(Sigma, St. Louis, MO) and 0.54mM EDTA (Sigma) and
the cells were cultured in plastic dishes at 37°C/5% CO2
in glial medium, which consisted of Minimum Essential
Medium (Invitrogen) supplemented with 10% [v/v]
horse serum (Invitrogen), 0.7% [w/v] glucose (Sigma)
and 16 μg/ml gentamicin (Invitrogen). The cells were
typically passaged 5-10 times and then cryopreserved for
future use. To prepare neuronal cultures, the cerebral
cortex of one P0 mouse was dissociated in PBS contain-
ing 0.025% [w/v] Trypsin, 0.27mM EDTA (Sigma) and
0.5% [w/v] DNase-I. The dissociated cells were plated
onto glass-bottomed dishes that had been coated with
poly-D-lysine (Sigma) and laminin (BD Biosciences, San
Jose, CA). Glass coverslips bearing glia (>80% con-
fluency) were suspended over the neurons using dots of
paraffin wax as spacers, and the resulting sandwich cul-
tures were maintained initially at 37°C/5% CO2 in plat-
ing medium, which consisted of Neurobasal medium
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ment Mixture (Invitrogen), 0.27% [w/v] glucose, 2 mM
glutamine (Invitrogen), 37.5 mM NaCl (Sigma), 5% [v/v]
fetal bovine serum (FBS; Thermo Scientific, Waltham,
MA), 16 μg/ml gentamicin, and 2.5 μMc y t o s i n ea r a b i -
noside (AraC; Sigma). After two days, the plating med-
ium was replaced with culturing medium, which was
identical to the plating medium except that it lacked
serum. Every four days, half the medium was removed
and replaced with fresh medium.
Transfection
The dissociated cortical neurons were transfected by
electroporation prior to plating using an Amaxa Nucleo-
fector™ (Lonza Inc., Walkersville, MD) with the mouse
neuron nucleofection kit (VPG-1001) and program O-
05. The volume of the cell suspension was 100 μla n d
the cell density ranged from 4 × 10
6 to 6 × 10
6 cells/ml.
For the experiments on neurofilament movement and
distribution, we used 2 μg EGFP-mNFM construct
either alone or in addition to 2 μg N256S-kinesin-1A or
2 μg wild type kinesin-1A construct. For the microtu-
bule polarity experiments, we used 2 μgY F P - E B 1
construct.
Live-cell imaging
To image neurofilament movement, cortical neurons
were observed after 8 to 12 days in culture by epifluor-
escence microscopy on a Nikon TE300 inverted micro-
scope (Nikon, Garden City, NY) using a 100x Plan Apo
VC 1.4NA oil immersion objective. The observation
medium consisted of Hibernate-E (BrainBits, Springfield,
IL) supplemented with 2% [v/v] B27 Supplement Mix-
ture, 0.3% [w/v] glucose, 1 mM L-glutamine, 37.5 mM
NaCl, and 10 μg/ml gentamicin. The temperature on
t h em i c r o s c o p es t a g ew a sm a i n t a i n e du s i n ga nA i r
Stream incubator (Nevtek, Williamsville, VA). A layer of
dimethylpolysiloxane fluid (Sigma, 5 centistokes) was
floated over the observation medium to prevent eva-
poration. For time-lapse imaging, the exciting light from
the mercury arc lamp was attenuated 12-fold using neu-
tral density filters, and images were acquired with one
second exposures at four second intervals using a
Micromax 512BFT cooled CCD camera (Roper Scienti-
fic, Trenton, NJ) and MetaMorph™ software (Molecular
Devices, Sunnyvale, CA). All movies were 15 minutes in
length. It was necessary to adjust the focus occasionally
during movie acquisition to correct for focus drift. To
image YFP-EB1 comets, cortical neurons were observed
after 8-10 days in culture by epifluorescence microscopy
using a Nikon TE2000 microscope. For these experi-
ments, the exciting light from the mercury arc lamp was
attenuated 4-fold using neutral density filters, and
images were acquired with one second exposures at two
second intervals for two minutes using a CoolSNAP HQ
cooled CCD camera and 2 × 2 pixel binning (Roper
Scientific). For publication, the movies were saved in
QuickTime format using the H.264 video codec.
Motion analysis
Neurofilament movement was analyzed by tracking the
position of the leading or trailing ends of the filaments
in successive frames of the time-lapse image movies
using MetaMorph™ software. All objects greater than or
equal to 10 pixels (1.31 μm) in length were analyzed if
they moved a total distance of at least 50 pixels (6.55
μm) and could be tracked through at least three succes-
sive frames of the movie. To calculate the frequency of
movement, we classified each neurofilament as antero-
grade or retrograde based on its preferred direction of
motion and then counted the number of anterograde
and retrograde moving filaments per movie. Thus for
each movie we obtained two frequency measurements,
one anterograde and one retrograde. Ninety seven per-
cent of the filaments exhibited a preferred direction of
movement, defined as moving at least 70% of their time
in the same direction. The remaining 3% of the fila-
ments, which spent more than 30% of the time moving
in the opposite direction, were each considered to repre-
sent separate anterograde and retrograde moving events.
To calculate the flux, we grouped all the filaments in
each 15-minute movie together and measured the total
anterograde and retrograde distance moved. Thus for
each movie we obtained two flux measurements, one
anterograde and one retrograde. For the analysis of bout
velocity, bout duration and bout distance, we defined a
bout of movement to be a phase of uninterrupted move-
ment between two pauses or between a pause and a
reversal. Thus each bout velocity represents the bout
distance divided by the bout duration. Bouts in which
the filament was moving at the start or end of the
movie were ignored because their true duration could
not be assessed. Statistical comparisons were performed
using the Mann-Whitney test.
Immunofluorescence microscopy
Cells were fixed with 4% paraformaldehyde ten or eleven
days after plating and then extracted with PBS contain-
ing 1% [v/v] Triton X-100 and 0.3 M NaCl. For immu-
nostaining, the cells were stained first with a rabbit
polyclonal specific for NFM (AB1987; Chemicon, MA,
1:200) and then subsequently with a mouse monoclonal
antibody specific for beta-tubulin (N357; Amersham, NJ,
1:400) and a goat polyclonal antibody specific for GFP
(Goat anti-GFP; Rockland, 1:2000). The secondary anti-
bodies were Alexa 488-donkey anti-goat (Invitrogen,
1:200), Alexa 568-donkey anti-mouse (Invitrogen, 1:200),
and Alexa 647-donkey anti-rabbit (Invitrogen, 1:200).
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(Invitrogen, 1:20) in the secondary antibody mixture.
Coverslips were mounted using ProLong Gold Antifade
reagent (Invitrogen). Images were acquired on a Nikon
TE2000 microscope with a 40x Plan Apo 1.0 NA oil
immersion objective and a CoolSNAP HQ cooled CCD
camera. The epifluorescent illumination was attenuated
4-fold using neutral density filters, and images were
acquired with 100 millisecond exposures. To quantify
the fluorescence in the distal axon, we measured the
fluorescence intensity in the most distal 100 μmo fe a c h
axon, extending proximally from the base of the growth
cone.
Additional material
Additional file 1: Movie showing abundant neurofilament
movement in a neuron expressing GFP-NFM. An example of the
abundant movement that can be observed in cultured cortical neurons
expressing GFP-NFM. Proximal is left and distal is right. Width of field of
view: 67 μm. Time compression: 40:1
Additional file 2: Movie showing abundant neurofilament
movement in a neuron expressing GFP-NFM. An example of the
abundant movement that can be observed in cultured cortical neurons
expressing GFP-NFM. This axon is branched, and filaments can be
observed to move from the parent axon into the daughter axons and
vice versa. Proximal is left and distal is right. Width of field of view: 67
μm. Time compression: 40:1
Additional file 3: Movie showing neurofilament movement in a
neuron expressing GFP-NFM. A gap in the axonal neurofilament array
of a cortical neuron expressing GFP-NFM. A single neurofilament moves
through the gap. Proximal is left and distal is right. Width of field of
view: 67 μm. Time compression: 40:1
Additional file 4: Movie showing neurofilament movement in a
neuron co-expressing GFP-NFM and N256S-kinesin-1A. A gap in the
axonal neurofilament array of a cortical neuron co-expressing GFP-NFM
and N256S-kinesin-1A. Some jiggling movement is apparent at the edges
of the gap, but no filaments move into the gap. Proximal is left and
distal is right. Width of field of view: 67 μm. Time compression: 40:1
Additional file 5: Movie showing neurofilament movement in a
neuron co-expressing GFP-NFM and wild type kinesin-1A. A gap in
the axonal neurofilament array of a cortical neuron co-expressing GFP-
NFM and wild type kinesin-1A. A neurofilament moves through the gap
and then a shorter filament enters that gap. Proximal is left and distal is
right. Width of field of view: 67 μm. Time compression: 40:1
Additional file 6: Movie showing microtubule plus-end “comets” in
a neuron expressing YFP-EB1. Microtuble plus-end “comets” in the
axon of a cortical neuron expressing YFP-EB1. Proximal is left and distal is
right. Note that all the comets move anterogradely, confirming the plus-
end distal orientation of the microtubules in these axons. A kymograph
generated from this movie is shown in Figure 7A. Width of field of view:
42 μm. Time compression: 20:1
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